Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.
Zymtronix has raised $2.0M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2021.
Zymtronix's investors include National Science Foundation.
Zymtronix is headquartered in Ithaca, United States.
Zymtronix develops a patented platform technology that allows innovative and efficient enzyme processes.
Zymtronix is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Zymtronix — Funding & Investors." VCBacked, December 1, 2021, https://www.vcbacked.co/company/zymtronix. Accessed August 14, 2026.
VCBacked. (2021). Zymtronix — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/zymtronix
{{cite web |title=Zymtronix — Funding & Investors |url=https://www.vcbacked.co/company/zymtronix |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated